From: Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
Trial Number
Scan 1 (week 6)
Scan 2
Scan 3
Scan 4
Scan 5
A1
PD
A2
B2
SD
C2
C3